Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats
Zhongya Chen,1,2 Jiaxin Deng,1,2 Yan Zhao,1,2 Tao Tao1,21National Pharmaceutical Engineering Research Center, 2Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of ChinaBackground: Integrins αv&a...
Guardado en:
Autores principales: | Chen Z, Deng J, Zhao Y, Tao T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/15b20fa854d14fa7a54d4d31e24e52d9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects
por: Song Z, et al.
Publicado: (2017) -
Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide
por: Li C, et al.
Publicado: (2013) -
Cyclic RGD-conjugated Pluronic® blending system for active, targeted drug delivery
por: Lim C, et al.
Publicado: (2018) -
Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation
por: Kang MJ, et al.
Publicado: (2013) -
Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake
por: Li X, et al.
Publicado: (2011)